Department of Pathology and Biomedical Science, University of Otago, Christchurch, PO Box 4345, Christchurch, 8140, New Zealand.
Department of Pathology and Biomedical Science, University of Otago, Christchurch, PO Box 4345, Christchurch, 8140, New Zealand; Centre for Postgraduate Nursing Studies, University of Otago, Christchurch, PO Box 4345, Christchurch, 8140, New Zealand.
Free Radic Biol Med. 2022 Feb 1;179:208-212. doi: 10.1016/j.freeradbiomed.2021.11.029. Epub 2021 Nov 21.
Septic shock is a life-threatening dysregulated response to severe infection and is associated with elevated oxidative stress. We aimed to assess protein carbonyls in critically ill patients with different sources of sepsis and determine the effect of vitamin C intervention on protein carbonyl concentrations.
Critically ill patients with septic shock (n = 40) were recruited, and sources of sepsis and ICU severity scores were recorded. The patients were randomised to receive either intravenous vitamin C (100 mg/kg body weight/day) or placebo infusions. Blood samples were collected at baseline and daily for up to three days for measurement of cell counts, vitamin C concentrations, protein carbonyls, C-reactive protein, and myeloperoxidase concentrations.
Protein carbonyl concentrations increased 2.2-fold in the cohort over the duration of the study (from 169 to 369 pmol/mg protein; p = 0.03). There were significant correlations between protein carbonyl concentrations and ICU severity scores (APACHE III r = 0.47 and SOFA r = 0.37; p < 0.05) at baseline. At study admission, the patients with pneumonia had nearly 3-fold higher protein carbonyl concentrations relative to the patients with other sources of sepsis (435 vs 157 pmol/mg protein, p < 0.0001). The septic patients had deficient vitamin C status at baseline (9.8 ± 1.4 μmol/L). This increased to 456 ± 90 μmol/L following three days of intravenous vitamin C intervention. Vitamin C intervention did not attenuate the increase in protein carbonyl concentrations.
Circulating protein carbonyls are specifically elevated in critically ill patients with pneumonia relative to other sources of sepsis. The reasons for this are currently unclear and may indicate a mechanism unique to pulmonary sources of sepsis. Intravenous vitamin C administration did not attenuate the increase in protein carbonyls over time.
感染性休克是一种严重感染引起的危及生命的失调反应,与氧化应激升高有关。我们旨在评估不同来源脓毒症的危重症患者的蛋白羰基水平,并确定维生素 C 干预对蛋白羰基浓度的影响。
纳入脓毒症性休克的危重症患者(n=40),记录脓毒症的来源和 ICU 严重程度评分。患者随机接受静脉注射维生素 C(100mg/kg 体重/天)或安慰剂输注。在基线和最多三天内每天采集血液样本,用于测量细胞计数、维生素 C 浓度、蛋白羰基、C 反应蛋白和髓过氧化物酶浓度。
研究期间,队列中蛋白羰基浓度增加了 2.2 倍(从 169 增加到 369 pmol/mg 蛋白;p=0.03)。在基线时,蛋白羰基浓度与 ICU 严重程度评分(APACHE III r=0.47 和 SOFA r=0.37;p<0.05)存在显著相关性。在研究入院时,肺炎患者的蛋白羰基浓度几乎比其他来源的脓毒症患者高 3 倍(435 比 157 pmol/mg 蛋白,p<0.0001)。脓毒症患者在基线时存在维生素 C 缺乏状态(9.8±1.4 μmol/L)。静脉注射维生素 C 干预三天后,该值增加至 456±90 μmol/L。维生素 C 干预并没有减轻蛋白羰基浓度的升高。
与其他来源的脓毒症相比,肺炎危重症患者的循环蛋白羰基水平明显升高。其原因目前尚不清楚,可能表明肺源性脓毒症的一种独特机制。静脉注射维生素 C 给药并不能随时间减轻蛋白羰基的增加。